4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org


BioGenerator News

St. Louis’ Phas3 Lands Paid Pilot at Colorado Hospitals

Dec 17, 2019

BioGenerator-supported digital health company wins $20k cash + contract Phas3, a St. Louis-based company providing remote cardiac rehab, has won Colorado’s Prime Health Challenge, which will allow Phas3 to pilot its […]

Read More

Biotech startup Canopy buys California analysis firm

Dec 13, 2019

Canopy Biosciences, a 2-year-old St. Louis company providing genomics products and services, made its second acquisition this week. Canopy announced Wednesday that it bought Core Diagnostics, a Hayward, California, provider of biomarker […]

Read More

St. Louis Digital Health Company Readout Health Produces New Class 1 Medical Device to Easily Track Nutritional Ketosis

Dec 12, 2019

BioGenerator-backed company is first to manufacture digital health device in St. Louis St. Louis digital health company Readout Health is set to help millions of people manage their health through […]

Read More

BioGenerator Agtech Startup Benson Hill Launches New Seed Company

Dec 04, 2019

Crop Innovation Company Introduces New Seed Company Focused on High-Performance Food & Feed Grade Soybeans Growers can tap into growing markets with expanded offerings of high-quality, high-yielding varieties ST. LOUIS, […]

Read More

Rapidly Growing BioGenerator Startup Canopy Biosciences Acquires San Francisco Company

Dec 04, 2019

ST. LOUIS, Dec. 4, 2019 /PRNewswire/ — Canopy Biosciences, LLC announced today the acquisition of Core Diagnostics, a leading CLIA-certified provider of biomarker analysis services for biopharmaceutical researchers. With the […]

Read More

BioGenerator & Cultivation Capital co-lead over-subscribed Series A for tech-enabled services company Healthy Bytes

Nov 27, 2019

ST. LOUIS – St. Louis talent and St. Louis investment have led Healthy Bytes to relocate its headquarters from New York to St. Louis. With investments from Cultivation Capital and […]

Read More

BioGenerator Company Galera Therapeutics Goes Public with $60M IPO

Nov 07, 2019

Galera Therapeutics has raised a $60 million in an initial public offering. The company, which is developing treatments to reduce the harmful effect of radiation therapy, raised the $60 million […]

Read More

Job Opening — Venture Capital Fellows Program

Oct 23, 2019

BioGenerator is seeking qualified candidates to join our team and help us achieve our mission of promoting economic growth and regional prosperity.  BioGenerator, the non-profit investment arm of BioSTL, was […]

Read More

BioGenerator Company Indalo Therapeutics Initiates Dosing in Idiopathic Pulmonary Fibrosis (IPF) Patients

Oct 21, 2019

Indalo Therapeutics Initiates Dosing in IPF Patients with Lead Antifibrotic Drug Candidate IDL-2965 October 21, 2019 Key milestone reached in adaptive Phase 1/1b clinical trial that began in April 2019 […]

Read More

BioGenerator Company VaxNewMo Publishes Latest Results in Proceedings of the National Academy of Sciences

Aug 29, 2019

BioGenerator portfolio company noted for its ‘promising technology’ to more quickly and affordably bring vaccines to market ST. LOUIS – St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors